Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Pernicious anemia Pernicious anemia has been estimated to affect approximately 2% to 3% of individuals over 65 years of age (5)
my 3rd order qnd I will keep ordering
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
Standard employment drug tests do not screen for peptide hormones
No changes in fasting glucose, insulin, HbA1c, IGF-1, cortisol, or thyroid hormones were detected at any dose tested
Your dose may need to go up as you progress through treatment, but your price remains the same across all dosage levels
US$ 21.87
US$ 27.93
US$ 22.39
